Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I consortium study

Lars M. Wagner, Peter C. Adamson, Susan M. Blaney et al.|Pediatric Blood & Cancer|2010

Cited by 73